March 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday issued a draft guidance to help companies reduce ...
MedPage Today on MSN
FDA Proposes More Flexibility in Alternatives to Animal Testing in Drug Development
Non-animal testing methods could save drugmakers time and money, officials say ...
Morning Overview on MSN
FDA urges alternatives to animal testing in early-stage drug development
The U.S. Food and Drug Administration is actively steering drug developers away from traditional animal studies and toward human-biology-based testing methods for monoclonal antibody programs. The ...
The FDA has released a draft guidance outlining how drug developers can validate new approach methodologies (NAMs) as alternatives to animal testing in preclinical drug developmen ...
FDA’s NAM framework emphasizes context of use, human biological relevance, technical characterization, and fit-for-purpose ...
The landscape of workplace safety and personal health screenings in the Greater Boston area involves a variety of technical procedures that can often seem complex to the uninitiated. In a major ...
In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches. One year later, much speculation ...
Controversy has returned over the question of which drug-testing method the government should require for federal Drug & Alcohol Clearinghouse compliance. Two prominent trucking stakeholders are ...
ARLINGTON, MA - March 16, 2026 - PRESSADVANTAGE - Drug testing is a routine requirement across many workplaces and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results